SCHEMBL30319818

SCHEMBL30319818

O=Nc1c(-c2c(O)[nH]c3ccc(F)cc23)[nH]c2ccccc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 13/20 0.83
▸ CDK5R1 Q15078 12/20 0.83
▸ CDK5 Q00535 11/20 0.83
▸ GSK3A P49840 10/20 0.83
▸ CDK1 P06493 10/20 0.83
▸ CCNB1 P14635 9/20 0.83
▸ CCNB2 O95067 8/20 0.83
▸ CCNB3 Q8WWL7 8/20 0.83
▸ CCNE1 P24864 5/20 0.77
▸ CDK2 P24941 5/20 0.77
▸ CCNT1 O60563 2/20 0.77
▸ CDK9 P50750 2/20 0.77
▸ FLT3 P36888 5/20 0.74
▸ ALOX5 P09917 4/20 0.74
▸ STK17B O94768 2/20 0.74
▸ CCNA2 P20248 2/20 0.74
▸ AURKA O14965 2/20 0.74
▸ AURKB Q96GD4 2/20 0.74
▸ AURKC Q9UQB9 2/20 0.74
▸ MEN1 O00255 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indirubin-3-Monoxime SCHEMBL29354191 0.86 CDK5R1 (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL30319828 0.84 CDK5R1 (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL29484209 0.84 GSK3B (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL30141665 0.81 CDK5R1 (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL30309734 0.80 CDK5R1 (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL29361130 0.78 GSK3B (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL29924508 0.75 GSK3B (0.72) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL30278941 0.74 GSK3B (1.00) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL6345762 0.69 NPC1 (0.52) GSK3BCDK5R1CDK5GSK3ACDK1
SCHEMBL6976558 0.68 ALDH1A1 (0.72) MEN1LMNAMAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115969814-A Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same 法斯瑞斯公司 2023-04-18 — — CN disclosed
Send feedback